Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis

NCT00076336 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis
Hepatitis B, Chronic
Cirrhosis

Interventions

DRUG: Telbivudine
DRUG: Lamivudine
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals